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The carboxyl-terminal domain (CTD, residues 146-231) of the HIV-1 capsid (CA) protein plays an important
role in the CA-CA dimerization and viral assembly of the human immunodeﬁciency virus type 1. Disrupting the
native conformation of the CA is essential for blocking viral capsid formation and viral replication. Thus, it is
important to identify the exact nature of the structural changes and driving forces of the CTD dimerization that
take place in mutant forms. Here, we compare the structural stability, conformational dynamics, and association
force of the CTD dimers for both wild-type and mutated sequences using all-atom explicit-solvent molecular
dynamics (MD). The simulations show that Q155N and E159D at the major homology region (MHR) and W184A
and M185A at the helix 2 region are energetically less favorable than the wild-type, imposing profound negative
effects on intermolecular CA-CA dimerization. Detailed structural analysis shows that three mutants (Q155N,
E159D, and W184A) display much more ﬂexible local structures and weaker CA-CA association than the wild-
type, primarily due to the loss of interactions (hydrogen bonds, side chain hydrophobic contacts, and π-stacking)
with their neighboring residues. Most interestingly, the MHR that is far from the interacting dimeric interface is
more sensitive to the mutations than the helix 2 region that is located at the CA-CA dimeric interface, indicating
that structural changes in the distinct motif of the CA could similarly allosterically prevent the CA capsid formation.
In addition, the structural and free energy comparison of the ﬁve residues shorter CA (151-231) dimer with the
CA (146-231) dimer further indicates that hydrophobic interactions, side chain packing, and hydrogen bonds are
the major, dominant driving forces in stabilizing the CA interface.
Introduction
Human immunodeﬁciency retroviruses type 1 (HIV-1) can
initially self-assemble into immature, noninfectious, spherical
particles consisting of approximately 5000 Gag molecules.
1-3
Initiated by the viral protease, the Gag proteins are then cleaved
into different new proteins including matrix (MA), capsid (CA),
nucleocapsid (NC), and three smaller peptides.
1,4-6 During the
subsequent virus maturation, MA remains attached to the viral
membrane, whereas hundreds of chemically identical CA
proteins spontaneously assemble into large and complex capsid
structures with different morphologies that enclose the NC-RNA
complex. Genetic analyses have revealed that CA assembly is
essential to the understanding of the mechanism of viral activity,
infectivity, and assembly
6 and also important in the development
of new drugs.
7 CA is composed of two distinct folded domains,
an N-terminal domain (NTD) and a C-terminal domain (CTD),
in which these two domains are connected by a ﬂexible linker.
The NTD (residues 1-146) consisting of seven R-helices and
an extended proline-loop
5,8-10 is responsible for viral capsid
formation,
8 while the CTD (residues 148-231) consisting of
four R-helices is responsible for assembly of immature Gag
shell
11 and virion formation.
12
It is well-known that the CA protein can spontaneously
assemble into different molecular structures such as cones,
spheres, and long helical tubes both in vivo and in vitro.
9,13
The different capsid morphologies may represent different
assembly stages or pathways to stable virus capsids. Li et al.
9
reported image reconstructions of helical assemblies of the
HIV-1 CA protein in vitro using cryo-electron microscopy (cryo-
EM). They found that NTDs of CA were organized in hexameric
rings while CTDs of CA associated via dimeric contacts by
interacting with adjacent hexamers. Briggs and co-workers
13
also observed similar CA hexamers with local p6 symmetry in
vivo. Recently, Ganser-Pornillos et al.
14 reported a three-
dimensional structure of hexameric arrays of full-length HIV
CA at 9 Å resolution using the EM and image analysis.
14 All
these reports suggest that CA capsid assemblies share a similar
lattice organization (i.e., hexamerization of the NTDs and
dimerization of the CTDs) in vitro and in vivo, although the
detailed lattice parameters of hexameric packing are different
from those proposed for HIV CA structures. Mutational analyses
revealed that although mutations in both domains of the CA
protein can alter or abolish capsid assembly, virus replication
and infectivity, and protein stability,
5,15 mutations in the CTD
are more disruptive to capsid formation than mutations in the
NTD. The CA protein has been extensively studied with respect
to its molecular structure and biological function using a wide
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(NMR),
6 X-ray diffraction,
8,16 and cryo-electron microscopy
(EM),
5,9,13,17 as well as theoretical approaches including mo-
lecular dynamics (MD) simulation and normal-mode analysis
(NMA).
7,18 However, the precise nature of the folding pathway,
the driving force that determines the overall stability of the
capsid, and the packing and binding mode between NTDs and
CTDs remain unclear.
From a simulation point of view, it is a very challenging task
to directly investigate the self-assembly process of the virus
capsid, as well as the dynamic and structural properties of the
whole virus capsid, using conventional all-atom MD simulation
due to the large number of atoms (more than 1 million) and
possible assembly pathways. However, it is well-known that
the formation of the virus capsid requires formation of a stable
hexameric structure of NTDs and dimeric structure of CTDs
and that the dynamic behavior of the domain interface also
determines HIV infectivity, capside assembly, and protein
stability. Ganser-Pornillos et al.
5 tested 21 mutations in the
NTDs and 6 mutations at the CTDs to examine the assembly
ability of CA proteins into helical capsid in vitro. They found
that only M39A and A42D at the NTDs and W184A at the
CTDs severely attenuated the formation of cylindrical capsid,
thus reducing virus infectivity. Mammano et al.
19 reported that
conservative mutation of two invariant residues at the major
homology region (MHR) of the CTDs (Q155N and E159D)
signiﬁcantly abolished viral replication. Gamble et al.
8 also
conﬁrmed the importance of residues Trp184 and Met185 in
stabilizing the CTDs of the CA proteins. Thus, the disruption
of either hexameric organization formed by six NTDs or dimeric
interface associated by two CTDs correlates with the prevention
of HIV capsid formation. However, detailed atomic-resolution
structures of these mutants and the corresponding structural
correlation of the substituted residue with its neighboring
residues and the whole virus capsid have not been reported. In
this work, we have performed multiple all-atom, explicit-solvent
MD simulations to examine the structural stability and dynamics
of CTDs of the CA protein for the wild-type and mutated
sequences, particularly focusing on the impact of mutations on
the interactions at the dimeric interface. Four mutations at the
dimeric interface (W184A and M185A at the helix 2 region
and Q155N and E159D at the MHR) were carefully selected to
examine the effect of speciﬁc single point mutation on the
association force, structural stability, and folding of CTDs of
the CA protein (Table 1). These simulations allow us to obtain
detailed atomic-level information about the dynamic behavior
of the C-terminal domain interface of HIV-1 and its underlying
driving force, which is critical for stabilizing the dimeric
structure; in turn, these could allow us to identify pharmacologi-
cal targets to block the capsid formation.
Simulation Methods. Model Systems. The X-ray crystal
structure (resolution 2.6 Å, PDB code 1A43) of the C-terminal
dimerization domain of the HIV-1 CA protein (146-231) was
used as the starting point for all the MD simulations. In the
native HIV capsid, two CTDs form a dimeric structure along a
2-fold screw axis. Each CTD monomer contains four helical
structures: helix 1 (residues 161-174), helix 2 (residues
179-192), helix 3 (residues 196-205), and helix 4 (residues
211-217). Two CTDs form a dimeric interface via helix 2
packing along a C2 symmetry (Figure 1). All starting structures
of the mutants were built from the wild-type by replacing the
side chains of the targeted residues but without changing the
backbone conformations and side-chain orientations. Four
mutations were used in the simulations: W184A and M185A
located in helix 2 region, and Q155N and E159D located in
Table 1. General Properties of Simulation Systems
RMSD
a Rg
a
system mutation region dimer monomer monomer dimer monomer monomer
wild-type (146-231) 2.8 ( 0.4 2.3 ( 0.3 2.4 ( 0.3 15.8 ( 0.3 11.4 ( 0.2 11.3 ( 0.1
wild-type (151-231) 4.5 ( 0.3 2.8 ( 0.5 3.8 ( 0.3 15.6 ( 0.3 11.2 ( 0.1 11.3 ( 0.1
Trp184Ala (146-231) helix 2 6.7 ( 0.5 2.5 ( 0.2 3.4 ( 0.3 16.5 ( 0.3 11.7 ( 0.1 11.7 ( 0.2
Met185Ala (146-231) helix 2 3.1 ( 0.4 1.9 ( 0.2 2.0 ( 0.2 15.4 ( 0.2 11.5 ( 0.1 11.6 ( 0.2
Gln155Asn (146-231) MHR 5.9 ( 0.8 5.0 ( 0.6 3.6 ( 0.3 16.8 ( 0.5 11.2 ( 0.1 11.5 ( 0.2
Glu159Asp (146-231) MHR 5.4 ( 0.5 2.6 ( 0.2 3.8 ( 0.6 16.7 ( 0.2 11.7 ( 0.1 11.3 ( 0.3
a RMSD and Rg values were averaged for the last 10 ns.
Figure 1. Crystal dimeric structure of the C-terminal domain of CA
protein (146-231; PDB code 1A43). (a) Secondary structure of CA
dimer in cartoon representation. Each monomer consists of four
helixes: helix 1 (161-174; red), helix 2 (179-192; yellow), helix 3
(196-205; green), and helix 4 (211-217; purple). (b) Key residues
in the helix 2 with all side chain orientations facing the interface in
licorice representation (Glu180, Val181, Trp184, Met185, Thr188,
Leu189, and Gln192). The images are generated by VMD.
47
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mutant was ﬁrst minimized for 500 steps using the steepest
decent algorithm with the backbone of the protein restrained
before being subjected to the following system setup and
production runs. The N- and C-termini were blocked by acetyl
and amine groups, respectively.
MD Simulations. All MD simulations were performed using
the NAMD program
20 with the CHARMM27 force ﬁeld.
21-23
Each system was solvated by a TIP3P
24 water box with a
minimum distance of 10 Å from any edge of the box to any
protein atom. The periodic boundary condition and minimum
image convention were applied to all x, y, and z directions. The
standard simulation protocol consisting of initial minimization,
heating procedure, equilibrium, and production run was applied
to each MD simulation. Each system was initially energy
minimized using the conjugate gradient method for 5000 steps
with the protein constrained and for additional 5000 steps for
the whole system. The system was then subjected to 200 ps of
heating procedure, constraining the backbone atoms of the
protein to allow relaxation of water molecules. The following
1000 ps equilibrium run was performed without position
constraints on the protein. The production simulation used the
velocity verlet integrator with an NVT ensemble, a time step
of 2 fs, at a temperature of 300 K. The temperature was
controlled at 300 K by a Nose-Hoover thermostat. Van der
Waals interactions were calculated by the switch function with
a twin range cutoff of 10.0 and 12.0 Å and electrostatic
interactions were calculated by the force-shift function with a
cutoff of 12.0 Å. Nonbonded neighbor lists were updated
automatically based on the heuristic algorithm. Each system was
simulated for 20 ns and the trajectories were saved at 1.0 ps
intervals for later analysis. The details of the setup of the
simulations are listed in Table 1.
Interaction Energy. Dimeric structures were extracted from
explicit MD trajectories by excluding water molecules at a 10
ps time interval. Each structure was ﬁrst subjected to energy
minimization for 1000 conjugate gradient steps. At the mini-
mized state, the solvation energy was then calculated using the
Generalized Born with a simple switching method (GBSW).
25,26
Thus, the interaction energy between two dimers was calculated
by
〈∆Gdimer〉)Edimer
mm +Gdimer
gbsw -(Emonomer1
mm +Gmonomer1
gbsw )-
(Emonomer2
mm +Gmonomer2
gbsw ) (1)
where Emm is the molecular mechanical energy of the selected
system consisting of all bonded and nonbonded energy terms
in the CHARMM potential energy function. The monomer
trajectory is simply obtained from the dimer trajectory by
neglecting other solutes. The method has been used to examine
the binding energy of A  dimer
27,28 and von Hippel-Lindau
tumor suppressor protein complex.
29
Results and Discussion
Impact of Mutations at the Helix 2 Region (W184A
and M185A) on the Structure and Dynamics of the CA
Dimer. Figure 2 shows the backbone root-mean-square devia-
tion (RMSD) for the wild-type (146-231) and mutants W184A
and M185A. Trp184 and Met185 residues in the helix 2 are
deeply buried in the middle region of the dimeric interface. The
RMSDs of both the wild-type and M185A mutant were
maintained at 2.8 and 3.1 Å for 20 ns, respectively (Figure 2a
and Table 1), indicating that (i) both sequences were consider-
ably stable and (ii) replacement of Met185 with Ala has a little
inﬂuence on the overall stability of dimeric CTDs. In contrast,
when the large aromatic Trp184 was replaced by the small Ala
in the helix 2 region, the dimeric structure experienced a
relatively large structural deviation with a continuous increase
in rmsd of 7.3 Å. Consistent with the rmsd analysis, W184A
mutant also displayed the largest residue-based root-mean-square
ﬂuctuation (RMSF) as compared to the wild-type (Figure 2b),
in which the RMSF was used to assess the local dynamical
variation of each individual residue. There was no apparent
difference in the RMSF between the wild-type and the M185A
mutant. The RMSF proﬁle also shows that the all helix structures
were consistently stable, with RMSF around 1 Å, while the
linkers connecting helices were in general much more ﬂexible.
Especially, residues at the helix 2 regions that comprise the
dimeric interface have the lowest RMSF values, suggesting that
increased additional contacts indeed can reduce the ﬂuctuation
of the local secondary structure and of the overall protein
structure. This is not surprising: Similar stabilizing behavior
was also observed in other protein and peptide assemblies, in
which associations through noncovalent interactions between
the protein/peptide complexes mutually stabilize each other due
to the increased interactions at the interfaces. For example,
higher order aggregates of amyloid ﬁbrils generally exhibit more
stable molecular structures,
28,30,31 with the stability increasing
with size.
To further identify which interaction could affect the overall
stability of the dimeric structure, hydrogen bonds and side chain
contacts were calculated to estimate hydrophilic and hydropho-
bic interactions. A hydrogen bond is identiﬁed if the distance
between donor D and acceptor A is e3.5 Å and the angle
D-H···Ai se120°, while a side chain contact is deﬁned if
the center-mass-distance between sidechains is less than 6.5 Å.
Figure 2. Structural comparison and characterization of wild-type CA (146-231) and its mutants (W184A and M185A) at the helix 2 region. (a)
Backbone RMSD relative to the initial energy-minimized structure and (b) residue-based backbone RMSF relative to the average structure for
the wild-type and mutants. The rmsd shows structural deviation for the whole structure, while the RMSF shows structural ﬂuctuation for each
individual residue.
392 Biomacromolecules, Vol. 10, No. 2, 2009 Yu et al.The side chain of Trp184, which is located in the middle of
helix 2, extended into the dimeric interface and formed two
hydrogen bonds with Val181 and ﬁve side chain contacts with
its neighboring Trp184 and Val181 (Figure 3a). Two aromatic
rings in Trp184 are closely packed perpendicular to each other
to form a T-shape geometry, providing additional π-stacking
interactions to stabilize the dimeric interface.
32 Substitution of
Trp184 by the small alanine not only weakened these interac-
tions considerably (i.e., hydrogen bonds, side chain contacts,
and π-stacking), but also disrupted compact geometrical packing,
causing a dramatic displacement of one CTD domain shifting
∼6 Å relative to the other along the helix 2 axis (Figure 3b).
Interestingly, although the W184A mutant tended to disrupt the
dimeric interface, it imposes a little inﬂuence on the local
secondary structures since all helices were still well preserved
during the simulations. In contrast, the M185A substitution
caused no gross perturbation of the whole dimeric structure,
only subtle changes in the interaction sites (Figure 3c). Since
Met185 does not interact with neighboring residues at the
interface, an Ala substitution with comparable hydrophobicity
relative to Met will not introduce new interactions or consider-
ably lose existing interactions. It should be noted that in the
M185A mutant, Trp184 still dominated a large number of
interactions with Val181, Thr188, and Leu189 at the dimeric
interface of the M185A. Thus it is clear that Trp184 plays an
important role in orienting and stabilizing the CA dimer.
Impact of Mutations at the MHR Region (Q155N and
E159D) on the Structure and Dynamics of the CA Dimer.
The MHR region consisting of 20 amino acids (residues
153-172) forms a compact strand-turn-helix motif.
8 Gln155
and Glu159 are located at the edges of the turn and the
interactions between Gln155 and Glu159 stabilize the turn
structure and restrain the turn motion. It is generally accepted
that a turn/loop region is very ﬂexible and thus is vulnerable to
mutations.
33-35 To minimize the effect of the mutation residue
size and hydrophobicity at the target position, Asn was selected
to replace Gln155, while Asp was selected to replace Glu159;
Gln versus Asn and Glu versus Asp have comparable size and
hydrophobicity. Figure 4a clearly shows that both mutants
occurring at the MHR region experienced much larger structural
deviation than the wild-type, with the RMSD quickly rising to
a plateau of ∼5.5 Å. As expected, the RMSF proﬁle also showed
a similar increased trend with three sharp peaks occurring at
the MHR region (residues 155-159), the hinge connecting helix
1 and helix 2 (residues 174-178), and the hinge connecting
helix 3 and helix 4 (residues 205-210; Figure 4b). As shown
in Figure 5, Gln155 was closely packed against Ala194 and
Asn195 at the helix 2 region bridging the MHR and helix 2
motifs. Between the MHR and helix 2 regions, Gln155 formed
nine hydrogen bonds with Asn195 and Ala194, while within
the MHR region, Gln55 formed three hydrogen bonds with
Glu159 (Figure 5a). The Q155N substitution signiﬁcantly
disrupted the hydrogen-bond network of residue 155 with
Ala194, Asn195, and Glu159, decreasing from nine (wild-type)
to three (Q155N; Figure 5b). The loss of hydrogen bonding
and side chain contacts between the MHR and helix 2 regions
strongly affects the structural ﬂuctuation of the local turn region
(residues 155-159), as indicated by RMSF values rising from
1.81 Å (wild-type) to 4.47 Å (Q155N; Figure 4b). Interestingly,
although residue Glu159 is far from the helix 2 region and is
not involved in any contact with residues in the helix 2, E159D
also led to the loss of two hydrogen bonds and potential van
der Waals interactions within the MHR region (Figure 4c). As
a consequence, the turn restricted by Gln155 and Asp159
become more ﬂexible and free to move as compared to the turn
initially restricted by Gln155 and Glu159 so that hydrogen bonds
and side chain contacts between Gln155 and its neighboring
Asn195 and Ala194 tend to break and form easily. Taken
together, the substitution of Gln155 and Glu159 has a large
destabilizing effect not only on the local structure and dynamics,
but also on the overall organization of the CA dimer. The
structural instability of Gln155 and Glu159 could be attributed
to the loss of hydrogen bonds and van der Waal interactions. It
is reasonable to expect that substitutions at positions of 155
and 159, other than Q155N and E159D, will lead to even larger
structural perturbation in the loop due to the large differences
of molecular size and hydrophobicity of sidechains.
Interdomain and Intradomain Motions. To quantitatively
monitor speciﬁc interactions and relative motions of mutated
residues and their neighboring residues, four residue-pair
distances in the helix 2 region and three residue-pair distances
in the MHR region were selected and measured as a function
of simulation time. Figures 6a-c show the intermolecular
distances of four identical residue pairs at the dimeric interface
between E180I-E180II, Q192I-Q192II, W184I-W184II,o r
Figure 3. Intermolecular interaction network between the helix2I-
helix2II motifs forming a CA dimeric interface for (a) wild-type
(146-231), (b) W184A, and (c) M185A. All interacting residues are
labeled by their residue names. Hydrogen bonds are represented by
red dotted lines, while side chain contacts are represented by blue
dotted lines.
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and II represent different monomeric CTDs. Glu180 and Gln192
are located at the edges of the helix 2, while Trp184 and Met185
are located in the middle of the helix 2 with all sidechains
pointing toward the dimeric interface. Positions 180, 184, 185,
and 192, which are almost evenly distributed along helix 2, were
selected to monitor the opening-closing motions between two
CTDs. As can be seen in Figure 6a, all four residue pairs were
able to maintain their initial contacts at the dimeric interface
with small distance ﬂuctuations, indicating that the dimeric
interface is well preserved during the entire simulations. M185A
displayed some distance ﬂuctuation between Q192I-Q192II, but
no signiﬁcant difference was observed between the wild-type
and the mutant M185A (Figure 6c), primarily due to that short
Met185 did not involve many interactions with its neighboring
residues. In contrast, for the mutant W184A, all four residue-
pair distances experienced large ﬂuctuations, quickly increasing
within the ﬁrst 10 ns, which indicated that they lost their original
contacts at the helix2I-helix2II interface (Figure 6b). These
results suggest that the most critical interaction at the dimeric
interaction is W184I-W184II; whereas M185I-M185II interac-
tion has little effect on stabilization of the dimer interface.
Within the single CTD, the intramolecular distance is
calculated by averaging the mass center distance between
selected pair residues for the last 10 ns. The averaged distances
between Q155-E159, Q155-A194, and Q155-N195 in the
wild-type were 6.4 ( 0.2, 5.1 ( 0.2, and 5.9 ( 0.3 Å,
respectively. The Gln155 position is unique because Gln155
not only interacts with Glu159 to stabilize the hydrophobic turn
(Gly156-Pro157-Lys158) at the MHR region, but also forms
hydrogen bonds with Asn195 and Ala194, to associate with the
helix 2 and MHR motifs. It is expected that Gln155 will present
a large effect on the stability or conformation of the CA dimer.
The Q155N mutant quickly lost interactions with Asn195 and
Ala194 at the helix 2 region, as indicated by the continuous
increase in pairwise residue distances; however, the interactions
between Asn155 and Glu159 were well conserved (Figure 6e).
Interestingly, although Glu159 is far from the interface between
the MHR and helix 2 motifs and does not interact with Ala194
and Asn195, a replacement of Glu159 with Asp is likely to
allosterically perturb interactions near the turn region, with the
bent turn shifting slightly away from the MHR-helix2 interface.
Considering all three pairwise residue distances among the wild-
type and mutants at the MHR region, it is clear that both mutants
displayed larger ﬂuctuations of the selected distances than the
wild-type, indicating that mutants at the MHR region prefer a
ﬂexible conformation.
Figure 4. Structural comparison and characterization of wild-type CA (146-231) and its mutants (Q155N and E159D) at the MHR region. (a)
Backbone RMSD relative to the initial energy-minimized structure and (b) residue-based backbone RMSF relative to average structure for the
wild-type and mutants.
Figure 5. Intramolecular hydrogen bonding network between the turn
region (residues 155-159) and helix 2 (residues 179-192) for (a)
wild-type (146-231), (b) Q155N, and (c) E159D. Hydrogen bonding
interactions between residues 155 and 159 within the MHR region
were represented by red dotted lines, while hydrogen bonding
interactions between the residue at the position 155 (MHR region)
and residues of Ala194 and Asn195 (helix 2 region) were represented
by blue dotted lines.
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(151-231) Dimer with the CA (146-231) Dimer. Gamble
and co-workers
8 reported that the binding afﬁnity of CA
(146-231) protein dimer is almost the same as that of full-
length HIV protein, but they also found that a ﬁve-residue
shorter CA (151-231) can not be dimerized even at the high
concentration up to 100 µM, suggesting that the ﬁve missing
hydrophobic residues (Ser146-Pro147-Thr148-Ser149-Ile150)
could play an important role in the CA dimer formation. We
therefore performed an additional simulation to investigate the
stability and dynamics of the shorter CA (151-231) dimer for
comparison. Consistent with experimental observation,
8,16 the
simulation shows that the shorter CA (151-231) dimer dis-
played its instability with a continuously increasing RMSD up
to 4.5 Å, as compared to the RMSD of 2.8 Å for the stable CA
(146-231) dimer (Figure 7a). Structural comparison shows that
the ﬁve residues (Ser146-Ile150) in the CA protein are sitting
in the middle of a pocket formed by the helix2I-
helix2II-helix3II. Within 6.5 Å distance from these ﬁve residues,
Val181, Trp184, Met185, Gln187, Thr188, Lys189, Leu189,
Leu190, Lys203, Leu205 from the helix 2 and helix 3 formed
a strong hydrophobic contact network stabilizing the CA
(146-231) dimer (Table 3). The absence of these hydrophobic
interactions reduces the binding afﬁnity of the two CTDs and
the binding energy at the dimeric interface increases from
-131.8 kcal/mol for CA (146-231) to -87.9 kcal/mol for CA
(151-231; Table 2). It can be clearly seen in Figure 7c that as
compared to the CA (146-231) dimer, the loss of native
contacts at the dimeric interface (hydrogen bonds and side chain
contacts, Table 2) leads to the change in the relative orientation
of the two CTDs (151-231), in which one of the CTD
monomers is rotated away from the interface.
Overall CTD-CTD Interactions and Allosteric Effects.
The stability of the CTD dimeric complex is determined by
direct interactions between the proteins like hydrogen bonds,
salt bridge, hydrophobic effects, and van der Waals contacts.
31
Figure 6. Variations of pairwise interface residue distances at the selected positions of 192I-192II, 185I-185II, 184I-184II, and 180I-180II
between the helix2I-helix2II motifs for (a) wild-type, (b) W184A, and (c) M185A, where I and II indicate different CTD monomers. Variations of
pairwise residue distances at the selected positions of 155-159, 155-194, and 155-195 within the same CTD monomer for (d) wild-type
(146-231), (e) Q155N, and (f) E159D.
Table 2. Average Hydrogen Bonds, Sidechain Contacts, and
Interaction Energies between Two Monomeric CTDs for the last 10
ns
system
hydrogen
bonds
a
sidechain
contact
b
interaction
energy (kcal/mol)
wild-type (146-231) 8.7 ( 1.9 26.9 ( 5.9 -131.8 ( 10.2
wild-type (151-231) 7.0 ( 1.5 22.0 ( 3.0 -87.9 ( 9.1
Trp184Ala (146-231) 4.2 ( 1.2 19.2 ( 4.1 -85.4 ( 7.3
Met185Ala (146-231) 8.2 ( 2.2 24.9 ( 3.3 -90.9 ( 10.2
Gln155Asn (146-231) 4.0 ( 2.2 15.6 ( 4.7 -62.3 ( 14.0
Glu159Asp (146-231) 4.7 ( 2.1 19.3 ( 3.0 -63.5 ( 8.4
a Hydrogen bond is identiﬁed if the distance between donor D and
acceptor A is e3.5 A and the angle D-H···Åi se120°.
b Side-chain
contact is deﬁned if the center of mass distance between two side chains
is less than 6.5 Å.
Table 3. Interacting Contact Network within 6.5 Å Radius of
Three Residues (T148-S149-I150) with Helix 2 and Helix 3
distance (Å)
helix 2I
179-192
helix 2II
179-192
helix 3II
196-205
T148I M185 (5.5) W184 (2.2) K203 (6.1)
Q187 (3.1) L205 (2.9)
T188 (2.8)
S149I W184 (5.8) K203 (5.2)
Q187 (6.3) L205 (4.5)
T188 (5.6)
I150I V181 (6.1) W184 (4.7) K203 (6.4)
M185 (2.3) Q187 (5.5) L205 (6.5)
L189 (2.9) T188 (2.1)
L190 (5.8) L189 (6.3)
Q192 (6.1)
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underlying the association of CTDs, the interactions between
the two CTDs were calculated and compared among the wild-
type and four mutants (Figure 8). The average interaction
energies for the last 20 ns were -131.8 ( 10.2, -87.9 ( 9.1,
-85.4 ( 7.3, -90.9 ( 10.2, -62.3 ( 14.0, and -63.5 ( 8.4
cal/mol for the wild-type (146-231), wild-type (151-231),
W184A, M185A, Q155N, and E159D, respectively (Table 2
and Figure 8). The wild-type (146-231) has the most favorable,
lowest interaction energy consistent with previous structural
analysis, whereas the Q155N and E159D mutants have com-
parable unfavorable free energies. Comparing these interactions
among stable wild-type and unstable mutants suggests that the
overall CTD-CTD interactions are mainly controlled by van
der Waals interactions through side chain contacts, although
hydrogen bonds at the interface also contribute to the stabilizing
force to some extent. It is clear that the disruption of the speciﬁc
interactions by Trp184, Gln155, and Glu159 is responsible for
the loss of the total favorable interactions between the CA dimer,
leading to a tendency to dissociate. Subtle change in the MHR
region will result in large unfaVorable interactions for the whole
dimer, implying that the MHR region is an allosteric potential
mutation target for destabilizing the dimeric CA structure and
thus for preVenting HIV replication. Comparison of the interac-
tion energy among unstable mutants implies a more signiﬁcant
loss of interactions in the MHR than in the helix 2 region,
consistent with the structural analysis described above.
Biological Implications. Because HIV capsid assembly
depends on both CTD-CTD dimerization and NTD-NTD
hexamerization, the introduction of site mutations to lower the
binding afﬁnity/structural stability of the C-terminal dimerization
and N-terminal hexamerization is essential for preventing virus
replication.
36 The CA dimeric interface is mainly associated
through hydrophobic helix2I-helix2II interactions, consisting of
a cluster of four hydrophobic residues (Leu189, Met185, Trp184,
and Val181) in the middle of helix 2, and one polar residue
(Gln192) and one acidic residue (Glu180) at both ends of helix
2. Hydrophobic Trp184 and Met185 are deeply buried in the
dimer interface. Simulations show that the large aromatic Trp184
imposes strong stability by restricting the motions of nearby
residues. When the large Trp was replaced by the Ala at position
184, the smaller residue can not attain sufﬁcient packing
interactions with its neighboring residues, leading to the increase
of the structural ﬂexibility of the dimeric interface due to the
loss of interactions. Alcaraz et al.
15 and Ganser-Pornillos et al.
5
also observed that HIV capsid assembly is abolished when the
sole Trp184 is mutated to Ala. Unlike Trp184, structural analysis
of M185A does not show a signiﬁcant difference from the wild-
type 146-231, but the binding free energy of the dimeric
complex lost ∼40.9 kcal/mol as compared to the wild-type,
implying that some interactions could be lost upon the mutation.
In vitro experiments by Sitcht et al.
1 reported that the binding
afﬁnity of a capsid assembly inhibitor (CAI) for the M185A
mutant was reduced but not completely abolished in ELISAs.
Alamo et al. also found that Met185 did not contribute to
stability,
37 in agreement with our simulation results. Further-
more, Alanine scanning mutagenesis at the helix 2 region
showed that Ala substitutions at Glu180, Glu187, and Gln192
unexpectedly increase the afﬁnity of the CA dimer interface,
leading to more stable dimers.
15,37,38 This is not surprising: when
charged Glu residues are replaced by hydrophobic Ala, unfavor-
able electrostatic repulsions between Glu180-Glu180 and
Glu187-Glu187 pairs are eliminated and replaced by more
Figure 7. Structural analysis between wild-type CA (146-231) and truncated ﬁve-residue short CA (151-231). (a) Backbone RMSD relative to
initial energy-minimized structure, (b) residue-based backbone RMSF relative to average structure, and (c) structural superimposition of CA
(146-231, red color) with CA (151-231, cyan color). One CA (151-231) monomer tends to rotate away from the other.
Figure 8. Interaction energies between two facing CA monomers for
all wild-types and mutants.
396 Biomacromolecules, Vol. 10, No. 2, 2009 Yu et al.favorable hydrophobic interactions. The Gln192 residues are
located at the end of the helix 2 with the Gln192 side chains
substantially exposed to water. The hydrophilic Gln192-Gln192
interactions are weak, attacked by water molecules and easily
broken. This fact also indicates that hydrophobic interactions
are the major, dominant driving force in stabilizing the CA
interface.
Interestingly, the simulation results show that helix 2 is not
the only important motif that can be used to disrupt the CA
dimeric interface. It appears that the MHR is even more
venerable to mutation than the helix 2, via long-range allosteric
effects. Similar allosteric effects on the HIV-1 protease ﬂap that
is a target for drug design have also been observed.
39-42
Substitutions of conserved Gln155 by Asn and Glu159 by Asp
only result in subtle changes in the initial structures at the MHR
because Gln vs Asn and Glu vs Asp have similar molecular
size and hydrophobicity; thus, it is expected that these mutations
would neither introduce large new interactions, nor alter
backbone conformation. However, the simulations reveal the
unexpected consequence of dramatically reducing the binding
afﬁnity of CA dimerization, although the MHR is far from the
CA dimer interface. The MHR motif contains a ﬁve-residue
loop (Gln155-Gly156-Pro157-Lys158-Glu159) that co-
valently links the helix 1 and helix 2 motifs. The motion and
conformation of this loop is mainly restricted by the four most
highly conserved residues of Gln155, Gly156, Glu159, and
Arg167.
16 Especially, Gln155 is a key residue that bridges
Glu159 at the helix 1 with Asn195 and Ala194 at the helix 2
via hydrogen bonding (Figure 5). The disruption of this
hydrogen bonding network (Figure 5) could permit the motion
of the loop that exerts a stretching force to pull the helix 2 away
from the CA interface, destabilizing the binding of the CA
dimer. Gamble and co-workers
8 found that Q155N and E159D
mutants can block HIV-1 replication,
43 indicating that the
distinct motifs in the CA could perform the same function.
Conclusions
The CTD dimer interface is required for HIV capsid assembly.
Here, we have performed a series of MD simulations to study
the dynamics and stability of the HIV CA C-terminal domain
(146-231) dimer and its atomic-scale structural changes upon
single-point mutagenesis at the helix 2 and MHR regions. Four
mutation sites are carefully selected, Trp184 and M185 which
are deeply buried in the helix 2 region and Gln155 and Glu159
which regulate the loop motion at the MHR region. MD
simulations show that the disruption of the wild-type CA
C-terminal domain can destabilize the CA-CA dimerization
and thus inhibit HIV viral assembly. The Q155N and E159D
mutations at the MHR greatly destabilize the binding afﬁnity
of the CA dimer by disrupting the hydrogen bonding network
between the loop and the helix 1 and 2 motifs. This loop at the
MHR is a major target leading to the conformational changes
and unfolding of the CTD. At the helix 2 region, the W184A
mutation is known to abolish HIV CA protein assembly in vitro.
Substitution of the large, hydrophobic, and aromatic Trp184,
which is deeply buried in the helix 2 region by the small Ala,
not only weakens the hydrogen bonds, side chain contacts, and
π-stacking, but also disrupts compact geometrical packing,
causing a dramatic destabilization of the CA dimeric interface
as well. It appears that structural changes in the distinct motifs
of the CA could similarly prevent the CA capsid formation,
although the allosteric mutations at the MHR region affect the
structural stability and in particular the binding afﬁnity of the
CA dimer more than those occurring at the helix 2. Examination
of the relationships between the unstable mutants and the stable
wild-type and between structure and function suggest that the
hydrophobic interaction, side-chain packing, and hydrogen
bonds are important driving forces in stabilizing the CA dimer.
It is desirable to directly address the energetics, physico-
chemical stability, and folding of whole HIV capsid assembly
with both N- and C-terminal domains. We are currently applying
a new generic computational method based on symmetrical
assembly and 2D f 3D wrapping algorithm
44-46 to construct
the HIV protein tube without end or edge effects, and comparing
our structures with the full-length structure of HIV-1 CA
hexamer (Figure 9) as recently determined by Ganser-Pornillos
and co-workers.
14 This ongoing study will provide more detailed
insights into the mechanism of the HIV CA capsid formation.
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